When asthma interrupts sleep in children: What is the best strategy?

BioDrugs

Volumn 12, Issue 6, 1999, Pages 431-438

  Steenhuis, Trinette J ^a   Landstra, Anneke M ^b   Verberne, Anja A P H ^b   Van Aalderen, Wim M C ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ACADEMIC ACHIEVEMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CIRCADIAN RHYTHM; DRUG EFFECT; HUMAN; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LUNG FUNCTION; NIGHT SLEEP; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER;

EID: 0033388644     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199912060-00003     Document Type: Article

References (38)

1. 1. National asthma education program, expert panel on the mangement of asthma. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991; 88: 425-34
2. 2. Meijer GG, Postma DS, Wempe JB, et al. Frequency of nocturnal symptoms in asthmatic children who attend a hospital outpatient clinic. Eur Respir J 1995; 8: 2076-80
3. 3. Lenney W, Wells NEJ, O'Neill BA. The burden of paediatric asthma. Eur Respir Rev 1994 Apr; 18: 49-62
4. 4. Stores G, Ellis AJ, Wiggs L, et al. Sleep and psychological disturbance in nocturnal asthma. Arch Dis Chil 1998; 78: 413-9
5. 5. Meijer GG, Landstra AM, Postma DS, et al. The pathogenesis of nocturnal asthma. Clin Exp Allergy 1998; 28: 921-6
6. 6. Euler AR, Byrne WJ, Ament ME, et al. Recurrent pulmonary disease in children: a complication of gastroesophageal reflux. Paediatrics 1979; 63: 47-51
7. 7. De Vries K, Goei JT, Booy-Noord H, et al. Changes during 24 hours in the lung function and histamine hyperreactivtiy of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy 1962; 20: 90-101
8. 8. Van Aalderen WMC, Postma DS, Koëter GH, et al. Circadian change in bronchial responsiveness and nocturnal airflow obstruction in asthmatic children. Thorax 1989; 44: 803-7
9. 9. Soutar CA, Costello J, Ijaduola O, et al. Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion. Thorax 1975; 30: 436-40
10. 10. Kallenbach JM, Webster T, Dowdeswell R, et al. Heart rate control in asthma. Evidence of parasympathetic overactivity. Chest 1985; 887: 644-8
11. 11. Van Aalderen WMC, Postma DS, Koëter GH, et al. Nocturnal airflow obstruction, histamine, and the autonomic central nervous system in allergic children with asthma. Thorax 1991; 46: 366-71
12. 12. Morrison JFJ, Teale C, Pearson SB, et al. Adrenaline, broncho-constriction and asthma. BMJ 1990; 301: 473-6
13. 13. Martin RJ, Cicutto LC, Smith HR, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143: 351-7
14. 14. Mackay TW, Fitzpatrick MF, Douglas NJ. Non-adrenergic, non-cholinergic nervous system and overnight airway calibre in asthmatic and normal subjects. Lancet 1991; 338: 1289-92
15. 15. Berguist WE, Rachelefsly GS, Kadden M, et al. Gastroesophageal reflux-associated recurrent pneumonia and chronic asthma in children. Paediatrics 1981; 68: 29-35
16. 16. Hariparsad D, Wilson N, Dixon C, et al. Oral tartrazine in childhood asthma: effect on bronchial reactivity. Clin Allergy 1984; 14: 81-5
17. 17. Van Lookeren-Campagne JG, Knol K, De Vries K. House dust provocation in children. Scand J Respir Dis 1969; 50: 76-85
18. 18. Newman-Taylor AJ, Davies RJ, Hendrick OJ, et al. Recurrent nocturnal asthmatic reaction to bronchial provocation tests. Clin Allergy 1979; 9: 213-9
19. 19. Meijer GG, Van der Heide S, Postma DS, et al. House dust mite exposure in asthmatic and healthy children: the difference is carpeting. Pediatr Allergy Immunol 1995; 6: 187-91
20. 20. Meijer GG, Postma DS, Van der Heide S, et al. Exogenous stimuli and circadian peak expiratory flow variation in allergic asthmatic children. Am J Respir Crit Care Med 1996; 153: 237-42
21. 21. Meijer GG, Postma DS, Van der Heide S, et al. Seasonal variations in house dust mite exposure and the circadian peak expiratory flow amplitude in asthmatic children. Am J Crit Care Med 1996; 154: 881-4
22. 22. Van Aalderen WMC, Postma DS, Koëter GH, et al. The effect of reduction of maintenance treatment on circadian variation in peak expiratory flow rate values in asthmatic children. Acta Paediatr Scand 1988; 77: 269-74
23. 23. Kraan J, Koëter GH, Van der Mark TW, et al. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628-36
24. 24. Waalkens HJ, Gerritsen J, Koëter GH, et al. Budesonide and Terbutaline or Terbutaline alone in children with mild asthma. Effects on bronchial hyperresponsiveness and diurnal variation in peak flow rate. Thorax 1991; 46: 499-503
25. 2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992: 146; 547-54
26. 26. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide). Can it be achieved? Dutch CNSLD Study Group. Eur Respir J 1994; 7: 63-8
27. 27. Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis 1993; 148 (5): 1252-7
28. 28. Elias-Jones AC, Higenbottam TW, Barnes ND, et al. Sustained release theophylline in nocturnal asthma. Arch Dis Child 1984; 59: 1159-61
29. 29. Pederson S. Treatment of nocturnal asthma in children with a single dose of sustained-release theophylline taken after supper. Clin Allergy 1985; 15: 79-85
30. 30. Davies H, Stroobant J, Leakey T, et al. Once a day theophylline in chronic childhood asthma? Eur J Pediatr 1986; 145: 258-9
31. 31. Verberne AAPH, Frost C, Roorda RJ, et al. One year treatment with salmeterol compared to beclomethasone in children with asthma. Am J Respir Crit Care Med 1997; 156: 688-95
32. 32. Wempe JB, Tammeling EP, Postma DS, et al. Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma. J Allergy Clin Immunol 1992; 90: 349-57
33. 33. Kraft M, Wenzel SE, Bettinger CM, et al. The effect of salmeterol on nocturnal symptoms, airway function and inflammation in asthma. Chest 1997; 111: 1249-54
34. 34. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroids. Lancet 1994; 344: 219-24
35. 2 agonist. BMJ 1990; 301: 1365-68
36. 36. Dahl R, Pedersen B, Hagglof B. Nocturnal asthma: effect of treatment with oral sustained-release terbutaline, inhaled budesonide, and the two in combination. J Allergy Clin Immunol 1989; 73: 811-5
37. 37. Meijer GG, Postma DS, Mulder PGH, et al. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled steroids. Am J Respir Crit Care Med 1995; 152: 1887-92
38. 38. Mackowiak JI, Lawrence BJ, Boyer J, et al. Effects of salmeterol on sleep scores using a quality of life instrument in patients with mild/moderate asthma. Am Rev Respir Dis 1993; 147: A 60